SectorPharmaceutical
Established Date31/10/2012
Listing Date07/06/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees4
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1185 Avenue of the Americas, 3rd Floor , New York, New York 10036
Business
IntroductionTAO Synergies Inc., was incorporated in Delaware on October 31, 2012. The company is a biopharmaceutical company with product candidates in preclinical and clinical development. The Company is primarily focused on developing a product platform based on a drug candidate called Bryostatin-1, synthesized from a natural product (bryostatin) isolated from marine invertebrate organisms for the treatment of Alzheimer's disease (" AD "), which is in clinical testing.
